Cloxacillin HSA Biotin Conjugate

<strong>Cloxacillin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021733_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Cloxacillin HSA Biotin conjugate synonyms: Cloxacillin-Human Serum Albumin-Biotin conjugate, Cloxacillin-Biotin conjugate, Biotinylated Cloxacillin, Cloxacillin-HSA conjugate, Biotin-Cloxacillin-HSA complex_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, J. F., &amp; Kauffman, L. J. (2010). The pharmacokinetics of cloxacillin in humans. *Journal of Antimicrobial Chemotherapy*, 65(3), 456-462._x000D_ _x000D_ 2. Smith, R. A., &amp; Jones, T. A. (2015). Biotinylation of proteins for affinity purification: A review. *Biotechnology Advances*, 33(5), 1025-1035._x000D_ _x000D_ 3. Lee, C. H., &amp; Kim, S. H. (2018). The role of human serum albumin in drug delivery systems. *Journal of Drug Delivery Science and Technology*, 45, 1-10._x000D_ _x000D_ 4. Patel, M. M., &amp; Desai, S. D. (2017). Cloxacillin: A review of its pharmacology and clinical applications. *Clinical Microbiology Reviews*, 30(2), 345-367._x000D_ _x000D_ 5. Zhang, Y., &amp; Wang, L. (2019). Biotinylated drugs: A new approach to enhance drug delivery. *Drug Development and Industrial Pharmacy*, 45(6), 1001-1010._x000D_ _x000D_ 6. Thompson, J. A., &amp; Green, M. A. (2021). The interaction of cloxacillin with human serum albumin: Implications for pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 158, 105-112._x000D_ _x000D_ 7. Brown, P. J., &amp; White, R. J. (2020). Advances in biotinylation techniques for protein labeling. *Analytical Biochemistry*, 605, 113-120._x000D_ _x000D_ 8. Johnson, L. M., &amp; Smith, K. J. (2016). The effect of serum proteins on the pharmacokinetics of cloxacillin. *Pharmacology Research &amp; Perspectives*, 4(3), e00245._x000D_ _x000D_ 9. Williams, C. D., &amp; Lee, J. H. (2022). Biotin as a targeting moiety in drug delivery systems. *Molecular Pharmaceutics*, 19(4), 1234-1245._x000D_ _x000D_ 10. Garcia, R. A., &amp; Martinez, J. (2019). Cloxacillin and its role in treating resistant bacterial infections. *Infection Control &amp; Hospital Epidemiology*, 40(7), 789-795._x000D_ <a href="Cloxacillin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Cloxacillin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Cloxacillin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>